FI883585A0 - Menetelmä verihiutalesolun pinta-antigeenin läsnäolon toteamiseksi - Google Patents
Menetelmä verihiutalesolun pinta-antigeenin läsnäolon toteamiseksiInfo
- Publication number
- FI883585A0 FI883585A0 FI883585A FI883585A FI883585A0 FI 883585 A0 FI883585 A0 FI 883585A0 FI 883585 A FI883585 A FI 883585A FI 883585 A FI883585 A FI 883585A FI 883585 A0 FI883585 A0 FI 883585A0
- Authority
- FI
- Finland
- Prior art keywords
- surface antigen
- determining
- present
- platelet cell
- provides
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 3
- 101710160107 Outer membrane protein A Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/29—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the position or the direction of light beams, i.e. deflection
- G02F1/31—Digital deflection, i.e. optical switching
- G02F1/313—Digital deflection, i.e. optical switching in an optical waveguide structure
- G02F1/3131—Digital deflection, i.e. optical switching in an optical waveguide structure in optical fibres
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/35—Non-linear optics
- G02F1/3515—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam
- G02F1/3517—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer
- G02F1/3519—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer of Sagnac type, i.e. nonlinear optical loop mirror [NOLM]
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F3/00—Optical logic elements; Optical bistable devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Nonlinear Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Rehabilitation Therapy (AREA)
- Zoology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Power Engineering (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93612586 | 1986-12-01 | ||
US06/936,125 US4810632A (en) | 1986-12-01 | 1986-12-01 | Cell surface antigen detection method |
US12490587 | 1987-11-24 | ||
US07/124,905 US5176998A (en) | 1986-12-01 | 1987-11-24 | Cell surface antigen detection method |
US8703129 | 1987-11-25 | ||
PCT/US1987/003129 WO1988004432A1 (en) | 1986-12-01 | 1987-11-25 | Cell surface antigen detection method |
Publications (4)
Publication Number | Publication Date |
---|---|
FI883585A0 true FI883585A0 (fi) | 1988-07-29 |
FI883585A FI883585A (fi) | 1988-07-29 |
FI95082B FI95082B (fi) | 1995-08-31 |
FI95082C FI95082C (fi) | 1995-12-11 |
Family
ID=26823073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI883585A FI95082C (fi) | 1986-12-01 | 1988-07-29 | Menetelmä verihiutalesolun pinta-antigeenin läsnäolon toteamiseksi |
Country Status (9)
Country | Link |
---|---|
US (2) | US5176998A (fi) |
EP (1) | EP0290595B1 (fi) |
JP (1) | JP2803824B2 (fi) |
AT (1) | ATE123341T1 (fi) |
AU (1) | AU594554B2 (fi) |
DE (1) | DE3751331T2 (fi) |
DK (1) | DK173838B1 (fi) |
FI (1) | FI95082C (fi) |
NO (1) | NO172910C (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5176998A (en) * | 1986-12-01 | 1993-01-05 | The Scripps Research Institute | Cell surface antigen detection method |
US5525461A (en) * | 1991-11-01 | 1996-06-11 | T Cell Diagnostics, Inc. | Therapeutic and diagnostic methods using total leukocyte surface antigens |
US5731425A (en) * | 1994-10-28 | 1998-03-24 | Eastman Kodak Company | Polypeptide surface marker for cells |
US6984526B2 (en) | 1995-02-08 | 2006-01-10 | University Of South Florida | Spectrophotometric method for determining the viability of a sample containing platelets |
US6330058B1 (en) | 1999-04-14 | 2001-12-11 | University Of South Florida | Spectrophotometric method and apparatus for blood typing |
US6379903B1 (en) | 1999-10-08 | 2002-04-30 | Sigma-Aldrich Co. | Purification of recombinant proteins fused to multiple epitopes |
CA2740192C (en) | 2008-12-01 | 2019-12-31 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detection of complement fixing antibodies |
WO2012070964A1 (ru) * | 2010-11-22 | 2012-05-31 | Farber Boris Slavinovich | Модифицированные олигопептиды с противораковыми свойствами и способ их получения |
EP2972348B1 (en) | 2013-03-14 | 2018-08-15 | The Board of Trustees of The Leland Stanford Junior University | Methods of detecting donor-specific antibodies |
US10527613B2 (en) | 2015-11-10 | 2020-01-07 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarker detection methods and systems and kits for practicing same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342566A (en) * | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
US4443427A (en) * | 1982-06-21 | 1984-04-17 | Sidney Farber Cancer Institute, Inc. | Monoclonal antibody |
US4643971A (en) * | 1983-03-11 | 1987-02-17 | Sloan-Kettering Institute | Monoclonal antibodies to human bladder and ureter cancers and method |
EP0149168B1 (en) * | 1983-12-19 | 1991-04-24 | Daiichi Pure Chemicals Co. Ltd. | Immunoassay |
US4695538A (en) * | 1984-06-01 | 1987-09-22 | Sloan-Kettering Institute For Cancer Research | Human monoclonal antibodies to cell surface antigens |
EP0169729A3 (en) * | 1984-07-23 | 1988-08-03 | Becton Dickinson and Company | Recovery of cell receptors |
US4670394A (en) * | 1984-11-16 | 1987-06-02 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C |
US5176998A (en) * | 1986-12-01 | 1993-01-05 | The Scripps Research Institute | Cell surface antigen detection method |
US4810632A (en) * | 1986-12-01 | 1989-03-07 | Scripps Clinic And Research Foundation | Cell surface antigen detection method |
-
1987
- 1987-11-24 US US07/124,905 patent/US5176998A/en not_active Expired - Lifetime
- 1987-11-25 DE DE3751331T patent/DE3751331T2/de not_active Expired - Lifetime
- 1987-11-25 JP JP63500784A patent/JP2803824B2/ja not_active Expired - Lifetime
- 1987-11-25 AT AT88900625T patent/ATE123341T1/de not_active IP Right Cessation
- 1987-11-25 AU AU10876/88A patent/AU594554B2/en not_active Expired
- 1987-11-25 EP EP88900625A patent/EP0290595B1/en not_active Expired - Lifetime
-
1988
- 1988-07-29 NO NO883367A patent/NO172910C/no not_active IP Right Cessation
- 1988-07-29 DK DK198804265A patent/DK173838B1/da not_active IP Right Cessation
- 1988-07-29 FI FI883585A patent/FI95082C/fi not_active IP Right Cessation
-
1992
- 1992-10-28 US US07/967,449 patent/US5336597A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK426588A (da) | 1988-07-29 |
FI95082B (fi) | 1995-08-31 |
US5176998A (en) | 1993-01-05 |
DK173838B1 (da) | 2001-12-10 |
NO172910C (no) | 1993-09-22 |
AU594554B2 (en) | 1990-03-08 |
FI95082C (fi) | 1995-12-11 |
FI883585A (fi) | 1988-07-29 |
DE3751331D1 (de) | 1995-07-06 |
DE3751331T2 (de) | 1996-02-01 |
ATE123341T1 (de) | 1995-06-15 |
NO883367D0 (no) | 1988-07-29 |
DK426588D0 (da) | 1988-07-29 |
EP0290595B1 (en) | 1995-05-31 |
US5336597A (en) | 1994-08-09 |
NO172910B (no) | 1993-06-14 |
JP2803824B2 (ja) | 1998-09-24 |
AU1087688A (en) | 1988-06-30 |
EP0290595A1 (en) | 1988-11-17 |
JPH01501571A (ja) | 1989-06-01 |
NO883367L (no) | 1988-07-29 |
EP0290595A4 (en) | 1990-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1313616C (en) | Lateral flow, non-bibulous membrane protocols | |
NO890981D0 (no) | Peptider og antistoffer som inhiberer blodplateadhesjon. | |
WO1985001354A1 (en) | Detecting an immunological reaction with activated red blood cells (erythrocytes) | |
FI883585A0 (fi) | Menetelmä verihiutalesolun pinta-antigeenin läsnäolon toteamiseksi | |
AU559966B2 (en) | Assaying antibody-antigen reactions | |
IE862504L (en) | Monoclonal antibody to leukocytes | |
NO331074B1 (no) | Analysemetode for bestemmelse av holo-Transcobalamin II i en cellefri prove i et kroppsfluid. | |
ES2176347T3 (es) | Modulacion de la respuesta inmune. | |
ATE18920T1 (de) | Radioimmunoassay fuer fibrinopeptid a. | |
GR3005971T3 (fi) | ||
IT8023609A0 (it) | Composizioni atte a separare le emazie dal siero o plasma in campioni di sangue per analisi emetodo che le utilizza. | |
ES8703021A1 (es) | Procedimiento para detectar y determinar la concentracion de un analito presente en solucion acuosa | |
AU2353188A (en) | A diagnostic agent and a method for the determination of apolipoprotein b | |
ES535553A0 (es) | Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico. | |
DE3674933D1 (de) | Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase. | |
DE3482924D1 (de) | Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene. | |
Maidment Jr et al. | Isoelectric focusing analysis of soluble immune complexes bound to Protein A-Sepharose | |
NO881998D0 (no) | Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker, og middel til gjennomfoering av fremgangsmaaten. | |
DE3863270D1 (de) | Immuntest. | |
IT9006603A1 (it) | Test immunoenzimatico classe specifico per la ricerca e determinazione degli anticorpi anti-cardiolipina nel siero. | |
DK305084A (da) | Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION |